Get the Stockscreener App
28.55
0.01%
-0.0024
After Hours:
28.55
0.0024
+0.01%
Franklin Genomic Advancements Etf Stock (HELX) Forecast
The Franklin Genomic Advancements Etf (HELX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $33.40, representing a +17.01% increase from the current price of $28.55. The highest analyst price target is $35.02, and the lowest is $31.78.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HELX Price Target
Average 33.85
(+18.56% Upside)
Is Franklin Genomic Advancements Etf (HELX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.80 | Buy |
| STOCH(9,6) | 25.80 | Neutral |
| STOCHRSI(14) | 2.2214 | Buy |
| MACD(12,26) | -0.5907 | Sell |
| ADX(14) | 24.74 | Neutral |
| William %R | -91.81 | Buy |
| CCI(14) | -209.50 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
30.50
Sell
|
30.10
Sell
|
| MA20 |
30.66
Sell
|
30.62
Sell
|
| MA50 |
31.65
Sell
|
31.35
Sell
|
| MA100 |
32.17
Sell
|
31.67
Sell
|
| MA200 |
31.88
Sell
|
31.23
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, HELX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on HELX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.8 indicates that HELX is oversold. This indicates that HELX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 25.8 indicates that HELX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.2214 indicates that HELX is oversold. This suggests that HELX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.74 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -209.5 indicates that HELX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term HELX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Franklin Genomic Advancements Etf financial reports and earnings history, Franklin Genomic Advancements Etf (HELX) stock could reach $49.34 by 2030, $89.04 by 2040 and $117.30 by 2050. See the projected annual prices until 2050 of the Franklin Genomic Advancements Etf stock below:
- Franklin Genomic Advancements Etf (HELX) is expected to reach an average price of $68.45 in 2035, with a high prediction of $68.68 and a low estimate of $67.35. This indicates an $139.78% rise from the last recorded price of $28.55.
- Franklin Genomic Advancements Etf (HELX) stock is projected to chart a bullish course in 2040, with an average price target of $88.84, representing an $211.19% surge from its current level. The forecast ranges from a conservative $87.98 to a sky-high $89.04.
- Our analysts predict Franklin Genomic Advancements Etf (HELX) to jump 246.64% by 2045, soaring from $98.72 to an average price of $98.96, potentially reaching $104.86. While $98.72 is the low estimate, the potential upside is significant.
- Franklin Genomic Advancements Etf (HELX) stock is expected to climb by 2050, reaching an average of $117.30, a $310.89% jump from its current level. However, a wide range of estimates exists, with high and low targets of $117.30 and $114.37, respectively, highlighting the market's uncertainty.
Franklin Genomic Advancements Etf Stock (HELX) Year by Year Forecast
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2024
Our forecast for HELX stock price in 2024 now indicates an average price target of $31.47 with a high forecast of $35.36 and a low forecast of $27.58. The average prediction reflects an increase of +10.23% from the last recorded price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $32.60 | $31.78 | $35.02 | +14.19% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2025
Franklin Genomic Advancements Etf Stock (HELX) is expected to reach an average price of $33.89 in 2025, with a high prediction of $37.88 and a low estimate of $29.89. This indicates an +18.70% rise from the last recorded price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $31.01 | $31.01 | $33.15 | +8.64% |
| February, 2025 | $30.87 | $29.89 | $31.66 | +8.12% |
| March, 2025 | $32.81 | $30.44 | $32.81 | +14.95% |
| April, 2025 | $34.76 | $32.54 | $35.55 | +21.76% |
| May, 2025 | $34.57 | $33.99 | $35.28 | +21.08% |
| June, 2025 | $36.69 | $34.39 | $36.69 | +28.52% |
| July, 2025 | $37.60 | $36.38 | $37.80 | +31.70% |
| August, 2025 | $34.39 | $34.25 | $37.69 | +20.45% |
| September, 2025 | $35.17 | $34.46 | $35.67 | +23.19% |
| October, 2025 | $33.97 | $32.21 | $35.45 | +18.98% |
| November, 2025 | $34.89 | $32.77 | $35.10 | +22.21% |
| December, 2025 | $37.57 | $34.90 | $37.88 | +31.61% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2026
The predicted value for Franklin Genomic Advancements Etf (HELX) in 2026 is set at an average of $38.60. Estimates vary from a peak of $42.68 to a trough of $34.52, indicating an +35.22% surge from the present price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $37.13 | $36.37 | $37.92 | +30.07% |
| February, 2026 | $38.72 | $36.79 | $38.88 | +35.65% |
| March, 2026 | $40.08 | $38.12 | $40.12 | +40.41% |
| April, 2026 | $38.48 | $38.48 | $40.24 | +34.78% |
| May, 2026 | $37.42 | $36.71 | $38.14 | +31.09% |
| June, 2026 | $34.73 | $34.73 | $37.75 | +21.65% |
| July, 2026 | $37.22 | $34.52 | $37.22 | +30.36% |
| August, 2026 | $39.07 | $36.91 | $39.24 | +36.87% |
| September, 2026 | $39.26 | $38.75 | $40.29 | +37.53% |
| October, 2026 | $40.32 | $39.18 | $40.32 | +41.25% |
| November, 2026 | $42.40 | $39.84 | $42.46 | +48.51% |
| December, 2026 | $41.83 | $41.52 | $42.68 | +46.54% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Franklin Genomic Advancements Etf (HELX) is $40.98, with a high forecast of $45.12 and a low forecast of $36.84. This indicates an +43.55% increase from the last price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $39.95 | $39.17 | $42.21 | +39.93% |
| February, 2027 | $37.93 | $37.93 | $40.48 | +32.86% |
| March, 2027 | $38.96 | $36.84 | $39.08 | +36.46% |
| April, 2027 | $39.80 | $39.06 | $39.93 | +39.41% |
| May, 2027 | $41.88 | $39.74 | $42.67 | +46.69% |
| June, 2027 | $42.07 | $41.14 | $42.41 | +47.35% |
| July, 2027 | $44.26 | $42.24 | $44.88 | +55.03% |
| August, 2027 | $44.92 | $44.06 | $45.12 | +57.34% |
| September, 2027 | $42.46 | $41.63 | $45.03 | +48.74% |
| October, 2027 | $41.45 | $41.35 | $42.96 | +45.20% |
| November, 2027 | $40.93 | $39.15 | $41.57 | +43.37% |
| December, 2027 | $42.20 | $39.77 | $42.20 | +47.83% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2028
In 2028, Franklin Genomic Advancements Etf (HELX) is projected to reach an average price of $45.65, with a high projection of $49.84 and a low estimate of $41.47. This indicates an +59.92% rise from the last price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $44.68 | $41.95 | $44.98 | +56.49% |
| February, 2028 | $44.30 | $43.52 | $45.04 | +55.16% |
| March, 2028 | $46.35 | $43.98 | $46.35 | +62.35% |
| April, 2028 | $46.83 | $46.06 | $47.42 | +64.04% |
| May, 2028 | $44.23 | $44.09 | $47.56 | +54.93% |
| June, 2028 | $44.35 | $43.64 | $45.53 | +55.35% |
| July, 2028 | $41.70 | $41.47 | $44.65 | +46.08% |
| August, 2028 | $44.25 | $41.96 | $44.47 | +55.02% |
| September, 2028 | $46.90 | $44.30 | $46.90 | +64.30% |
| October, 2028 | $46.41 | $45.90 | $47.41 | +62.58% |
| November, 2028 | $48.36 | $46.38 | $48.51 | +69.40% |
| December, 2028 | $49.80 | $47.78 | $49.84 | +74.46% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2029
The 2029 price forecast for Franklin Genomic Advancements Etf Stock (HELX) is $48.11 on average, with a high prediction of $52.44 and a low estimate of $43.79. This represents an +68.54% increase from the previous price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $48.30 | $48.30 | $50.00 | +69.18% |
| February, 2029 | $47.27 | $46.55 | $48.00 | +65.60% |
| March, 2029 | $43.97 | $43.97 | $46.95 | +54.02% |
| April, 2029 | $45.95 | $43.79 | $46.07 | +60.96% |
| May, 2029 | $48.50 | $46.07 | $48.67 | +69.90% |
| June, 2029 | $49.04 | $48.42 | $49.78 | +71.79% |
| July, 2029 | $49.26 | $48.28 | $49.54 | +72.56% |
| August, 2029 | $52.09 | $49.47 | $52.16 | +82.48% |
| September, 2029 | $52.32 | $51.38 | $52.44 | +83.27% |
| October, 2029 | $49.83 | $49.01 | $52.18 | +74.56% |
| November, 2029 | $47.15 | $47.15 | $50.39 | +65.17% |
| December, 2029 | $47.15 | $46.10 | $47.91 | +65.16% |
Franklin Genomic Advancements Etf Stock (HELX) Price Forecast for 2030
Franklin Genomic Advancements Etf Stock (HELX) is expected to reach an average price of $51.25 in 2030, with a high forecast of $55.74 and a low forecast of $46.76. This signifies an +79.52% surge from the last price of $28.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $49.21 | $46.76 | $49.34 | +72.37% |
| February, 2030 | $51.37 | $49.16 | $52.16 | +79.94% |
| March, 2030 | $51.32 | $50.67 | $51.93 | +79.77% |
| April, 2030 | $53.59 | $51.18 | $53.59 | +87.72% |
| May, 2030 | $54.68 | $53.31 | $54.88 | +91.53% |
| June, 2030 | $51.61 | $51.47 | $54.81 | +80.79% |
| July, 2030 | $50.65 | $50.53 | $52.93 | +77.43% |
| August, 2030 | $50.21 | $48.42 | $50.79 | +75.89% |
| September, 2030 | $51.28 | $49.09 | $51.50 | +79.63% |
| October, 2030 | $54.15 | $51.36 | $54.45 | +89.67% |
| November, 2030 | $53.85 | $53.05 | $54.53 | +88.63% |
| December, 2030 | $55.59 | $53.58 | $55.74 | +94.72% |
0.46%
Cap:
|
Volume (24h):